Advertisement
SAN FRANCISCO, Jan. 15, 2020 /PRNewswire-PRWeb/ -- For the sixth consecutive year, Greenberg Traurig, LLP's global Life Sciences & Medical Technology Group hosted two events coinciding with the JP Morgan Healthcare Conference in San Francisco.
On Jan. 14 the group presented the lunchtime panel discussion, "Insiders' Views of Deal Makings," where seasoned executives from leading life sciences companies shared current trends, best practices, and pitfalls of deals including M&A, licensing, joint ventures, and strategic collaborations. They also shared predictions on what 2020 will hold for deal making. Panelists included:
The program was preceded by a private wine tasting and networking reception on Jan. 13, attended by more than 300 health care industry executives and investors.
In addition, Kate Black, a shareholder in the firm's Data, Privacy & Cybersecurity Practice in the Miami office, introduced companies at the Biotech Showcase on Jan. 14.
About Greenberg Traurig's Life Sciences & Medical Technology Group: Greenberg Traurig's Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group's attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2100 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.
SOURCE Greenberg Traurig, LLP
Advertisement
On Jan. 14 the group presented the lunchtime panel discussion, "Insiders' Views of Deal Makings," where seasoned executives from leading life sciences companies shared current trends, best practices, and pitfalls of deals including M&A, licensing, joint ventures, and strategic collaborations. They also shared predictions on what 2020 will hold for deal making. Panelists included:
- Debbie Alexander, Director, Business Development, 23andMe
- Shaun Grady, Senior VP, Business Development Operations, AstraZeneca
- Dr. Robert Mittendorff, Partner, Norwest Venture Partners
- Jeremy Sohn, Vice President, Global Head of Digital Business Development & Licensing, Novartis
The program was preceded by a private wine tasting and networking reception on Jan. 13, attended by more than 300 health care industry executives and investors.
In addition, Kate Black, a shareholder in the firm's Data, Privacy & Cybersecurity Practice in the Miami office, introduced companies at the Biotech Showcase on Jan. 14.
About Greenberg Traurig's Life Sciences & Medical Technology Group: Greenberg Traurig's Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group's attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2100 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.
SOURCE Greenberg Traurig, LLP
